Matches in Wikidata for { <http://www.wikidata.org/entity/Q92034672> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q92034672 description "article scientifique publié en 2020" @default.
- Q92034672 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q92034672 description "scientific article published on 15 April 2020" @default.
- Q92034672 description "wetenschappelijk artikel" @default.
- Q92034672 description "наукова стаття, опублікована 15 квітня 2020" @default.
- Q92034672 name "A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation" @default.
- Q92034672 name "A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation" @default.
- Q92034672 type Item @default.
- Q92034672 label "A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation" @default.
- Q92034672 label "A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation" @default.
- Q92034672 prefLabel "A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation" @default.
- Q92034672 prefLabel "A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation" @default.
- Q92034672 P1433 Q92034672-54060FE6-966C-4C39-A482-AB77ABC7BBA9 @default.
- Q92034672 P1476 Q92034672-A8001D8A-FC63-4521-99BB-8D8B28158457 @default.
- Q92034672 P2093 Q92034672-1B41B322-F5A0-4EC0-A93C-051AE3CBBEB3 @default.
- Q92034672 P2093 Q92034672-21425EDB-B9BC-4416-9253-3289FC6148AD @default.
- Q92034672 P2093 Q92034672-3D4CCCE8-46B9-4966-A3A4-6DB6FAF26C0B @default.
- Q92034672 P2093 Q92034672-3E75A508-F14D-4853-8A23-673F0E8AC4D9 @default.
- Q92034672 P2093 Q92034672-4BA24EA0-7B28-4C62-B31E-E648FE375D73 @default.
- Q92034672 P2093 Q92034672-57E5FEB7-C773-4EC4-A94D-540D58577A9E @default.
- Q92034672 P2093 Q92034672-8D9B5D1E-F486-4B35-9ACD-3C4A420443F0 @default.
- Q92034672 P2093 Q92034672-B014FB31-E864-4767-B6E0-FE35ED68F153 @default.
- Q92034672 P2093 Q92034672-C5E647C5-9559-44A8-8B58-7DF0167AA5DC @default.
- Q92034672 P2093 Q92034672-CA3A98E6-3A71-4ADE-A4D3-D3CCEB255F1F @default.
- Q92034672 P304 Q92034672-D913A374-0E46-4D05-9744-4D57D56145F4 @default.
- Q92034672 P31 Q92034672-A70536C1-073A-4A7A-BABC-EFDB0EC86974 @default.
- Q92034672 P356 Q92034672-3EA55129-6405-44A4-9E7E-73B43F08E265 @default.
- Q92034672 P478 Q92034672-B000C7FF-6E8F-4240-9CE0-B1E901F03469 @default.
- Q92034672 P577 Q92034672-7C6EF2D2-B5C7-49BE-B2A6-9D6DFEFAF857 @default.
- Q92034672 P698 Q92034672-9D770BD6-006A-4B97-8110-E3C6BFD28E24 @default.
- Q92034672 P921 Q92034672-D2834FF5-440C-4B7C-B955-0754DA5C9C1E @default.
- Q92034672 P356 J.EJCA.2020.02.016 @default.
- Q92034672 P698 32305010 @default.
- Q92034672 P1433 Q332260 @default.
- Q92034672 P1476 "A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation" @default.
- Q92034672 P2093 "Dinesh P de Alwis" @default.
- Q92034672 P2093 "Elliot Chartash" @default.
- Q92034672 P2093 "Hesham Aboshady" @default.
- Q92034672 P2093 "Kapil Mayawala" @default.
- Q92034672 P2093 "Lillian L Siu" @default.
- Q92034672 P2093 "Lokesh Jain" @default.
- Q92034672 P2093 "Mallika Lala" @default.
- Q92034672 P2093 "Noboru Yamamoto" @default.
- Q92034672 P2093 "Tommy Ruosi Li" @default.
- Q92034672 P2093 "Vikram Sinha" @default.
- Q92034672 P304 "68-75" @default.
- Q92034672 P31 Q13442814 @default.
- Q92034672 P356 "10.1016/J.EJCA.2020.02.016" @default.
- Q92034672 P478 "131" @default.
- Q92034672 P577 "2020-04-15T00:00:00Z" @default.
- Q92034672 P698 "32305010" @default.
- Q92034672 P921 Q13896859 @default.